NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/05/2026
Voltar para busca
Dado oficial do USPTO
CENCORA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
12/05/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42
Data de depósito
26/12/2023
Data de registro
12/05/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/05/2026
Última transação
12/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2024-11-00
Primeiro uso no comércio
2024-11-00
Código do desenho
5
Tipo de titular
03
Localização do titular
Conshohocken, PA, US
Examinador
GANESH, HARINI
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized word "CENCORA".
Titulares e representantes
Titulares
Cencora, Inc.
Representantes
Anita B. Polott Morgan, Lewis & Bockius LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific and technological servicesresearch and design in the field of new product design and scientific research in the field of pharmacovigilanceclinical data reviewchemistry data evaluation; Scientific research and laboratory researchall in the field of pharmaceuticalsmedicines and medical products; industrial analysis and research serviceslaboratory research services relating to pharmaceuticalspharmaceutical research servicesresearch and development of new products for others; consulting services for others in the field of designplanningimplementation project management in the field of pharmaceuticalsmedicines and medical products; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to laboratory testing of materials; pharmaceutical products development; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; information technology services for the pharmaceutical and healthcare industriesinformation technology consulting services relating to computer network designcomputer software designinformation technology architecture and infrastructureinstallationmaintenance and repair of computer software; quality control testing for others; materials testing and evaluation; product safety testing; consulting services for others in the field of designplanningimplementation project management of clinical trials; providing medical and scientific research information in the fields of pharmaceuticalsdrug safetyclinical researchclinical testing and clinical trials; Scientific and technological servicesresearch and design in the field of pharmaceutical developmentmedical devicesbiopharmaceuticals; scientifictechnologicalmedical and pharmaceutical research and development services; industrial analysis and research services in the field of pharmaceuticalsmedical devicesbiopharmaceuticals; research and development of new products for others; pharmaceutical drug development services; research and development of pharmaceutical preparations; scientifictechnologicalmedical research and pharmaceutical research services and analysis services for scientific and technological purposes; biological research; clinical researchscientific research in the nature of conducting clinical trials for others; providing medical research and scientific research information; provision of scientific information in the nature of scientific surveys; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics; consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; scientific research in the fields of pharmaceuticalsvaccinesmedicinebiologicsbiotherapeuticsbiosimilarstherapeutics; development of a web application software for entering and evaluating informative texts for pharmaceuticals and medical productsin particular instructions for usepackage insertsspecialist information and for the provision of various documents; database serviceselectronic storage of data in computer databases; conversion of data or documents from physical to electronic media; testinginspection or research of pharmaceuticals and medicines; designengineeringresearchdevelopment and testing services in the field of pharmaceuticalsmedical devicesbiopharmaceuticals; research in the field of gene therapy; consultancy relating to quality assurance servicesquality assurancequality controlquality evaluation and analysis in the field of pharmaceuticalspharmaceutical manufacturingmedical devicesbiopharmaceuticals; research services relating to scientific work; preparation of scientific research analyses and evaluations relating to pharmaceuticalsmedical devicesbiopharmaceuticals; development of pharmaceutical preparations and medicines; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; medical research laboratory services; computer serviceson-site management of information technology systems for the pharmaceutical and healthcare industries; scientific evaluation of the drugs of others to determine drug efficacy; research and development services for assessing the efficiency of pharmaceuticals; analysis and evaluation of product design for others; analysis and evaluation of product development for others; quality control and evaluation of goods of others to determine conformity with certification standards; quality testing of products for certification purposes; consulting and advice on drug safety and monitoring for product research and development purposes; consultancy services for the development and approval process of biological samples or chemical samples for therapeutic and diagnostic purpose; consultancy services for others in the field of designplanningimplementation and project management of clinical trialsscientific pharmacovigilance researchpharmaceutical and biotechnology product development; consultancy services in the fields of biotechnologypharmaceutical research and developmentlaboratory testing of materials and pharmacogenetics; research laboratory analysis service in the field of pharmaceuticals and biotechnology product development relating to the diagnosis and treatment of persons; Software as a service (SAAS) services featuring software for product development processes and regulatory compliance using artificial intelligence for supporting decision making processes; Software as a service (SAAS) services featuring software for supporting decision making processes; Software as a service (SAAS) services featuring software for collecting data related to clinical trialsdrug developmentdrug safety; Software as a service (SAAS) servicesautomation software for collecting data related to clinical trialsdrug developmentdrug safety; providing online non-downloadable computer programs for data processing; providing online non-downloadable unified communications software for integrating communications systems and tools; providing online non-downloadable assistive software for collecting data related to clinical trialsdrug developmentdrug safety
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
12/05/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
21/04/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
21/04/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/04/2026
IUAF
USE AMENDMENT FILED
20/10/2025
EISU
TEAS STATEMENT OF USE RECEIVED
20/10/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
22/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/02/2025
PUBO
PUBLISHED FOR OPPOSITION
25/02/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/02/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
22/01/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/01/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
22/01/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/12/2024
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
03/12/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
03/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/12/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
29/08/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
29/08/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/06/2024
GNRT
NON-FINAL ACTION E-MAILED
05/06/2024
CNRT
NON-FINAL ACTION WRITTEN
05/06/2024
DOCK
ASSIGNED TO EXAMINER
28/05/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/04/2024
NWAP
NEW APPLICATION ENTERED
26/12/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CENCORA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.